ERP abnormalities, particularly reduced duration-deviant MMN, represent promising biomarkers for early detection of psychosis risk and may aid in risk stratification and intervention planning. These results highlight the potential utility of ERPs as clinically accessible, low-cost neurophysiological tools for predicting transition in CHR populations.
Wei et al. (Fri,) studied this question.